Peritoneal Surface Disease Severity Score as a predictor of resectability in the treatment of peritoneal surface malignancies - 01/03/14
, Amer Alame, M.D., Richard Berri, M.D.Abstract |
Background |
We evaluated the clinical utility of the Peritoneal Surface Disease Severity Score (PSDSS) as a preoperative predictor of resectability in the treatment of peritoneal surface malignancies.
Methods |
Forty-nine patients were selected for cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and were stratified according to the PSDSS retrospectively.
Results |
Of 52 cytoreductive surgeries performed in 49 patients, HIPEC was performed in 33 cases (63%). We analyzed 31 cases of appendiceal and colorectal cancer patients who underwent CRS and HIPEC and 12 who underwent CRS only. 68% of the patients in whom CRS and HIPEC was performed were classified as PSDSS stage I or II. Contrastingly, all patients in whom CRS and HIPEC was unachievable were scored as PSDSS stage III or IV.
Conclusions |
The outcomes of this study suggest that the PSDSS can be used as a preoperative assessment tool to predict disease resectability in the treatment of peritoneal surface malignancies.
Le texte complet de cet article est disponible en PDF.Keywords : Peritoneal surface malignancies, Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy (HIPEC), Peritoneal surface disease severity score (PSDSS), Complete cytoreduction
Plan
| The authors declare no conflicts of interest. |
Vol 207 - N° 3
P. 403-407 - mars 2014 Retour au numéro
Article précédent
- Surgical, oncologic, and cosmetic differences between oncoplastic and nononcoplastic breast conserving surgery in breast cancer patients
- Patty L. Tenofsky, Phaedra Dowell, Terri Topalovski, Stephen D. Helmer
- The effect of timing of postmastectomy radiation on implant-based breast reconstruction: a retrospective comparison of complication outcomes
- Patrick Collier, Jeffrey Williams, Gautam Edhayan, Kamala Kanneganti, Elango Edhayan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?